Effects of heparin administration on Trypanosoma brucei gambiense infection in rats

The Journal of Parasitology
Kazuhiko NishimuraShinji Yamasaki

Abstract

We examined whether heparin administration influences in vivo trypanosome proliferation in infected rats. Administration of heparin every 8 hr via cardiac catheter inhibited growth of Trypanosoma brucei gambiense and prolonged survival of treated rats. Heparin administration increased lipoprotein lipase activity, high-density lipoprotein (HDL) concentration in the blood, and haptoglobin messenger RNA content of the liver. The presence of heparin in culture media did not directly affect proliferation of trypanosomes in vitro. However, the addition of plasma from infected rats treated with heparin to culture media decreased the number of trypanosomes. This effect was decreased by incubating the trypanosomes with benzyl alcohol, a known inhibitor of receptor-mediated endocytosis of lipoprotein. These data suggested that heparin administration reduced the number of trypanosomes in infected rats. Trypanosome lytic factor, a HDL and haptoglobin-related protein, protects humans and some animals from infection by Trypanosoma brucei brucei. In rats, increases in HDL and haptoglobin may affect the proliferation of T. b. gambiense.

References

Nov 12, 1990·Biochimica Et Biophysica Acta·D M Goldberg, T Chajek-Shaul
Apr 26, 1989·Biochimica Et Biophysica Acta·J B Swaney, M W Orishimo
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·A B Smith, S L Hajduk
Sep 1, 1997·Infection and Immunity·Madhavi MuranjanSamuel J Black
May 16, 2001·The Journal of Biological Chemistry·J DrainS L Hajduk
Apr 24, 2002·Antioxidants & Redox Signaling·Jun WangSamuel J Black
Oct 9, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Mun-Yong LeeIn-Sook Kim
Feb 21, 2003·European Journal of Immunology·Meiqing ShiHenry Tabel
Mar 7, 2003·Nature·Luc VanhammeEtienne Pays
Jul 31, 2003·Journal of Biomedical Materials Research. Part a·Sylvie Anastase-RavionDidier Letourneur

Citations

Jan 27, 2009·Infection and Immunity·Nicolas Antoine-MoussiauxDaniel Desmecht
Mar 31, 2015·Experimental Parasitology·J M AustenS A Reid
Dec 11, 2014·Critical Care Medicine·Ryan ZarychanskiCanadian Critical Care Trials Group
Nov 13, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chiara UrbinatiMarco Rusnati

Related Concepts

Indirect Thrombin Inhibitors
Haptoglobins
Liquaemin
Lipoprotein LIPASE
High Density Lipoprotein Cholesterol
Liver
Poly(A) Tail
Trypanosoma brucei gambiense
Nagana
Rats, Wistar

Related Feeds

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.